Stelvio Oncologylogo

Stelvio Oncology

Stelvio Oncology has developed an epigenetic signature based platform for identifying compounds that drive differentiation of cancer stem cells into benign cell types.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.stelvio-oncology.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
479 Jessie Street, CA 94103
San Francisco
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/stelvio-oncology” connections=”true” suffix=””]